Twist Bioscience

ISIN US90184D1000

 | 

WKN A2N7L2

Market cap (in EUR)
3,779 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Quote

Description

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare United States

Chart

Financials

Key metrics

Market capitalisation, EUR 3,779 m
EPS, EUR -1.15
P/B ratio 9.6
P/E ratio -
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 341 m
Net income, EUR -70 m
Profit margin -20.63%
Advertisement
JPMorgan
JPM Equity Premium Income Active ETFs
Upgrade your income.
Explore
Capital at risk

What ETF is Twist Bioscience in?

There are 41 ETFs which contain Twist Bioscience. All of these ETFs are listed in the table below. The ETF with the largest weighting of Twist Bioscience is the ARK Genomic Revolution UCITS ETF USD Accumulating.
ETF Weight Investment focus Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) 0.04%
Equity
United States
Small Cap
67
Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Acc 0.01%
Equity
World
Small Cap
Climate Change
451
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc 0.01%
Equity
United States
Multi-Factor Strategy
8
Global X Telemedicine & Digital Health UCITS ETF Acc USD 4.62%
Equity
World
Health Care
4
Xtrackers Portfolio UCITS ETF 1C 0.00%
Equity
World
Multi-Asset Strategy
733
Xtrackers MSCI World Small Cap UCITS ETF 1D 0.10%
Equity
World
Small Cap
10
L&G Russell 2000 US Small Cap Quality UCITS ETF 0.18%
Equity
United States
Small Cap
176
WisdomTree BioRevolution UCITS ETF USD Acc 2.29%
Equity
World
Health Care
Social/Environmental
Biotech
14
iShares Healthcare Innovation UCITS ETF 0.33%
Equity
World
Health Care
Social/Environmental
Innovation
856
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.04%
Equity
United States
Small Cap
216
UBS MSCI USA Select Factor Mix UCITS ETF USD dis 0.01%
Equity
United States
Multi-Factor Strategy
27
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.01%
Equity
World
Multi-Factor Strategy
201
iShares MSCI World Small Cap UCITS ETF 0.03%
Equity
World
Small Cap
7,169
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist) 0.03%
Equity
World
Small Cap
33
Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating 0.01%
Equity
North America
Social/Environmental
241
Global X Telemedicine & Digital Health UCITS ETF Dist GBP 4.62%
Equity
World
Health Care
0
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD 0.06%
Equity
United States
Small Cap
4,733
L&G Healthcare Technology & Innovation UCITS ETF USD Acc 1.89%
Equity
World
Health Care
Innovation
187
VanEck Genomics and Healthcare Innovators UCITS ETF A 0.52%
Equity
World
Health Care
Social/Environmental
Innovation
12
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 0.59%
Equity
World
Health Care
Social/Environmental
Innovation
8
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc) 0.00%
Equity
World
5,549
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc 0.04%
Equity
United States
Small Cap
57
UBS MSCI USA Select Factor Mix UCITS ETF USD acc 0.01%
Equity
United States
Multi-Factor Strategy
110
ARK Innovation UCITS ETF USD Accumulating 3.38%
Equity
World
Innovation
255
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc) 0.03%
Equity
World
Small Cap
1,602
ARK Genomic Revolution UCITS ETF USD Accumulating 9.48%
Equity
World
Health Care
Innovation
50
Global X Genomics & Biotechnology UCITS ETF 2.54%
Equity
World
Health Care
Biotech
25
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
534
Xtrackers Russell 2000 UCITS ETF 1C 0.09%
Equity
United States
Small Cap
2,432
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist) 0.00%
Equity
World
126
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc 0.01%
Equity
United States
Multi-Factor Strategy
24
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.02%
Equity
United States
Small Cap
2,171
Xtrackers MSCI World Small Cap UCITS ETF 1C 0.10%
Equity
World
Small Cap
119
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.23%
Equity
United States
Health Care
Biotech
46
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.01%
Equity
World
Multi-Factor Strategy
1,208
iShares Nasdaq US Biotechnology UCITS ETF 0.23%
Equity
United States
Health Care
Biotech
739
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD 0.01%
Equity
United States
Small Cap
853
iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.02%
Equity
World
Small Cap
366
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
26
Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating 0.00%
Equity
World
Social/Environmental
930
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc 0.04%
Equity
United States
Small Cap
35

Performance

Returns overview

YTD +115.57%
1 month +25.38%
3 months +45.82%
6 months +120.29%
1 year +112.42%
3 years +282.46%
5 years -30.69%
Since inception (MAX) +398.29%
2025 -36.00%
2024 +26.36%
2023 +52.57%
2022 -64.37%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 63.59%
Volatility 3 years 67.47%
Volatility 5 years 71.46%
Return per risk 1 year 1.77
Return per risk 3 years 0.83
Return per risk 5 years -0.10
Maximum drawdown 1 year -37.92%
Maximum drawdown 3 years -60.85%
Maximum drawdown 5 years -90.59%
Maximum drawdown since inception -93.76%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.